SizeTri Chemical Laboratories (4369.T) is a Japan Industrials company (Industrial Conglomerates) with a market value of $520M, the 1045th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥2,608 on 18 Nov 2026.
Performance Over six months the shares fell 24.0%, against -12.2% for the median peer and -1.4% for the Japan market (cap-weighted) — 3rd lowest of 9 in its peer set.
Growth Revenue grew 12.5% over the last twelve months (peer median +11.0%); the operating margin is 25.0% (peer median 5.3%).
Valuation It trades at 12.7× forward earnings against a peer median of 10.6× (3rd most expensive of 6).
Price implies For today's price to make sense, revenue must grow about 20% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 1.3 points below its cost of capital (14.6% WACC).
Next results Next results expected around 30 Nov 2026 (exchange calendar; dates can move).
Relative performance
Six months, rebased to 100: Tri Chemical Laboratories against the median of its 8 peers (local-currency closes).
Tri Chemical Laboratories financials
Reported figures in JPY; fiscal year ends 2026-01-31. TTM = trailing twelve months.
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Performance: 6-month against 1-month return
Up and to the right = strong over both horizons. Tri Chemical Laboratories is the large dot.
Fundamentals: revenue growth against valuation
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Tri Chemical Laboratories is the large dot.
Capital: growth delivered against growth the price implies
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Tri Chemical Laboratories is the large dot.
Tri Chemical Laboratories competitors and peer comparison
How Tri Chemical Laboratories compares with its peers
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
Tri Chemical Laboratories against its 8 peers (data as of 18 Nov 2026)
Measure
4369.T
Peer median
Rank in peer set
1-month return
-18.6%
-5.6%
3rd lowest of 9
6-month return
-24.0%
-12.2%
3rd lowest of 9
Distance from 52-week high
-41.5%
-29.6%
3rd lowest of 9
Revenue growth (TTM)
+12.5%
+11.0%
4th highest of 9
Operating margin
25.0%
5.3%
highest of 9
Forward P/E
12.7×
10.6×
3rd most expensive of 6
Growth the price implies (Req g, 7 yrs)
20.2%
14.1%
2nd most demanding of 6
Growth delivered (Del g)
+19.5%
+15.7%
3rd highest of 6
Hurdle (Req g minus delivered)
+0.7 pp
-4.1 pp
3rd most demanding of 6
ROIC minus cost of capital
-1.3 pp
-4.0 pp
3rd highest of 8
EV / EBITDA
8.9×
8.9×
3rd cheapest of 5
Net debt / EBITDA
-0.5×
-1.1×
3rd most indebted of 6
Peer table
Peer set: Industry: the same industry and sector in any market, nearest in size
Which companies are Tri Chemical Laboratories's closest peers?
The cockpit's peer set: Grupo Empresarial San Jose (GSJ.MC), China Boton (3318.HK), RF Materials (327260.KS), Hangzhou Tianyuan Pet Products (301335.SZ), Balmer Lawrie & (BALMLAWRIE.NS), Guangzhou Wahlap Technology (301011.SZ), Tsuburaya Fields (2767.T), DCM Shriram (DCMSHRIRAM.NS).
Is Tri Chemical Laboratories expensive compared with its peers?
On forward p/e it trades at 12.7× against a peer median of 10.6×, 3rd most expensive of 6 in its peer set. For today's price to make sense, revenue must grow about 20% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Tri Chemical Laboratories stock performed?
Over six months to 18 Nov 2026 the shares returned -24.0% against -12.2% for the median peer; over one year -13.4%.